Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study
- PMID: 27366183
- PMCID: PMC4904566
- DOI: 10.1155/2016/8435257
Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study
Abstract
Outpatient parenteral antimicrobial therapy (OPAT) is a safe and effective alternative to hospitalization for many patients with infectious diseases. The objective of this study was to describe the OPAT experience at a Canadian tertiary academic centre in the absence of a formal OPAT program. This was achieved through a retrospective chart review of OPAT patients discharged from Sunnybrook Health Sciences Centre within a one-year period. Between June 2012 and May 2013, 104 patients (median age 63 years) were discharged home with parenteral antimicrobials. The most commonly treated syndromes included surgical site infections (33%), osteoarticular infections (28%), and bacteremia (21%). The most frequently prescribed antimicrobials were ceftriaxone (21%) and cefazolin (20%). Only 56% of the patients received follow-up care from an infectious diseases specialist. In the 60 days following discharge, 43% of the patients returned to the emergency department, while 26% required readmission. Forty-eight percent of the return visits were due to infection relapse or treatment failure, and 23% could be attributed to OPAT-related complications. These results suggest that many OPAT patients have unplanned health care encounters because of issues related to their infection or treatment, and the creation of a formal OPAT clinic may help improve outcomes.
Figures

Similar articles
-
Assessing the utilization and impact of a newly established outpatient parenteral antimicrobial therapy (OPAT) program.J Assoc Med Microbiol Infect Dis Can. 2020 Jun 23;5(2):70-76. doi: 10.3138/jammi.2019-0018. eCollection 2020 Jun. J Assoc Med Microbiol Infect Dis Can. 2020. PMID: 36338181 Free PMC article.
-
Impact of a nurse practitioner-led dedicated outpatient parenteral antibiotic therapy clinic on patient outcomes and administrative workload: a retrospective cohort study.Ther Adv Infect Dis. 2024 Dec 23;11:20499361241305308. doi: 10.1177/20499361241305308. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 39717489 Free PMC article.
-
Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.BMC Infect Dis. 2017 Jul 6;17(1):474. doi: 10.1186/s12879-017-2569-4. BMC Infect Dis. 2017. PMID: 28683717 Free PMC article.
-
Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.Clin Pharmacokinet. 2003;42(9):793-817. doi: 10.2165/00003088-200342090-00002. Clin Pharmacokinet. 2003. PMID: 12882587 Review.
-
Outpatient parenteral antibiotic therapy: principles and practice.Eur J Intern Med. 2013 Oct;24(7):617-23. doi: 10.1016/j.ejim.2013.03.014. Epub 2013 Apr 18. Eur J Intern Med. 2013. PMID: 23602223 Review.
Cited by
-
Incidence and risk factors for healthcare utilisation among patients discharged on outpatient parenteral antimicrobial therapy.Epidemiol Infect. 2018 Apr;146(6):782-787. doi: 10.1017/S0950268818000456. Epub 2018 Mar 14. Epidemiol Infect. 2018. PMID: 29534769 Free PMC article.
-
Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.JAC Antimicrob Resist. 2019 Aug 26;1(2):dlz026. doi: 10.1093/jacamr/dlz026. eCollection 2019 Sep. JAC Antimicrob Resist. 2019. PMID: 34222901 Free PMC article. Review.
-
Assessing the utilization and impact of a newly established outpatient parenteral antimicrobial therapy (OPAT) program.J Assoc Med Microbiol Infect Dis Can. 2020 Jun 23;5(2):70-76. doi: 10.3138/jammi.2019-0018. eCollection 2020 Jun. J Assoc Med Microbiol Infect Dis Can. 2020. PMID: 36338181 Free PMC article.
-
Risk of Treatment Failure for Prosthetic Joint Infections: Retrospective Chart Review in an Outpatient Parenteral Antimicrobial Therapy Program.Can J Hosp Pharm. 2023 Jan 9;76(1):14-22. doi: 10.4212/cjhp.3264. eCollection 2023 Winter. Can J Hosp Pharm. 2023. PMID: 36683659 Free PMC article.
-
Does comorbidity index predict OPAT readmission?JAC Antimicrob Resist. 2023 Nov 23;5(6):dlad125. doi: 10.1093/jacamr/dlad125. eCollection 2023 Dec. JAC Antimicrob Resist. 2023. PMID: 38021037 Free PMC article.
References
-
- Rucker R. W., Harrison G. M. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54(3):358–360. - PubMed
-
- Wai A. O., Frighetto L., Marra C. A., Chan E., Jewesson P. J. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme: a Canadian teaching hospital and ministry of health perspective. PharmacoEconomics. 2000;18(5):451–457. doi: 10.2165/00019053-200018050-00004. - DOI - PubMed
-
- Barr D. A., Semple L., Seaton R. A. Outpatient Parenteral Antimicrobial Therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. International Journal of Antimicrobial Agents. 2012;39(5):407–413. doi: 10.1016/j.ijantimicag.2012.01.016. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources